Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.1B | 4.0B | 4.2B |
Cost of revenue | 1.9B | 1.8B | 1.7B | 1.7B |
Gross profit | 2.6B | 2.3B | 2.3B | 2.5B |
Operating expense | ||||
Research & development | 527M | 517M | 491M | 492M |
Selling general and admin | 485M | 472M | 446M | 428M |
Other operating expenses | — | — | — | — |
Operating income | 1.6B | 1.3B | 1.4B | 1.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 133M | 128M | 130M | 131M |
Other income expense | 48M | 80M | 112M | 131M |
Pretax income | 1.5B | 1.3B | 1.4B | 1.6B |
Tax provision | 183M | 97M | 154M | 192M |
Net income | 1.3B | 1.2B | 1.2B | 1.4B |
Basic EPS | 1.4 | 1.3 | 1.3 | 1.5 |
Diluted EPS | 1.4 | 1.3 | 1.3 | 1.5 |
Basic average shares | 908M | 910M | 912M | 913M |
Diluted average shares | 912M | 916M | 919M | 920M |
EBITDA | 2.1B | 1.8B | 1.9B | 2.1B |
Net income from continuing op. | 1.3B | 1.2B | 1.2B | 1.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | 7M | — | 6M | 7M |